Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder

Key Findings:  This review helps to summarize the current literature regarding the use of cannabidivarin (CBDV), and propyl analog of cannabidiol (CBD), in the treatment of autism spectrum disorders and epilepsy.

Type of Study:  Meta-analysis

Study Result:  Inconclusive

Study Location(s):  Italy

Year of Pub:  2021

Cannabinoids Studied:  Cannabidiol (CBD), Cannabinoid (unspecified), Cannabidivarin (CBDV)

Phytocannabinoid Source:  Unspecified